Epigenetic perspective into head and neck cancer through in silico gene expression profiling of histone lysine methyltransferases

Journal of Otolaryngology - Head and Neck Surgery

Volumn 37, Issue 3, 2008, Pages 366-372

  Biron, Vincent L ^a   Dort, Joseph C ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b NONE   (Canada)

Author keywords

Epigenetics; Histone methylation; Oncology

Indexed keywords

HISTONE LYSINE METHYLTRANSFERASE;

ARTICLE; CARCINOGENESIS; COMPUTER MODEL; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; EXPRESSED SEQUENCE TAG; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SEQUENCE; GENETIC ANALYSIS; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; MALIGNANT TRANSFORMATION; ONCOGENE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE TAGGED SITE; TUMOR SUPPRESSOR GENE;

EID: 64349105832     PISSN: 19160216     EISSN: None     Source Type: Journal    
DOI: 10.2310/7070.2008.0058     Document Type: Article

References (32)

1. Hunter KD, Parkinson EK, Harrison PR. Profiling early head and neck cancer. Nat Rev Cancer 2005;5:127-35.
2. Fan CY. Epigenetic alterations in head and neck cancer: prevalence, clinical significance, and implications. Curr Oncol Rep 2004;6:152-61.
3. Esteller M. Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br J Cancer 2006;94:179-83.
4. Yoo CB, Jones PA. Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov 2006;5:37-50.
5. Santos-Rosa H, Caldas C. Chromatin modifier enzymes, the histone code and cancer. Eur J Cancer 2005;41:2381-402.
6. Fischle W, Wang Y, Allis CD. Histone and chromatin cross-talk. Curr Opin Cell Biol 2003;15:172-83.
7. Jenuwein T. The epigenetic magic of histone lysine methylation. FEBS J 2006;273:3121-35.
8. Ha PK, Califano JA. Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. Lancet Oncol 2006;7:77-82.
9. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethy- lation profile of human cancer. Cancer Res 2001;61:3225-9.
10. Huang S. Histone methyltransferases, diet nutrients and tumour suppressors. Nat Rev Cancer 2002;2:469-76.
11. Schneider R, Bannister AJ, Kouzarides T. Unsafe SETs: histone lysine methyltransferases and cancer. Trends Biochem Sci 2002;27:396-402.
12. Valk-Lingbeek ME, Bruggeman SW, van Lohuizen M. Stem cells and cancer; the polycomb connection. Cell 2004;118:409-18.
13. Oh J, Lee J, Woo JM, et al. Systematic identification and integrative analysis of novel genes expressed specifically or predominantly in mouse epididymis. BMC Genomics 2006;7:314-30.
14. Wheeler DL, Church DM, Federhen S, et al. Database resources of the National Center for Biotechnology. Nucleic Acids Res 2003;31:28-33.
15. Lin W, Dent SY. Functions of histone-modifying enzymes in development. Curr Opin Genet Dev 2006;16:137-42.
16. Biron VL, McManus KJ, Hu N, et al. Distinct dynamics and distribution of histone methyl-lysine derivatives in mouse development. Dev Biol 2004;276:337-51.
17. Liu H, Kim JM, Aoki F. Regulation of histone H3 lysine 9 methylation in oocytes and early pre-implantation embryos. Development 2004;131:2269-80.
18. Seki Y, Hayashi K, Itoh K, et al. Extensive and orderly reprogramming of genome-wide chromatin modifications associated with specification and early development of germ cells in mice. Dev Biol 2005;278:440-58.
19. Margueron R, Trojer P, Reinberg D. The key to development: interpreting the histone code? Curr Opin Genet Dev 2005;15:163-76.
20. Sakai I, Tamura T, Narumi H, et al. Novel RUNX1-PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22). Genes Chromosomes Cancer 2005;44:265-70.
21. Chang DH, Cattoretti G, Calame KL. The dynamic expression pattern ofB lymphocyte induced maturation protein-1 (Blimp-1) during mouse embryonic development. Mech Dev 2002;117:305-9.
22. Nakayama Y, Stabach P, Maher SE, et al. A limited number of genes are involved in the differentiation ofgerminal center B cells. J Cell Biochem 2006.
23. Pasqualucci L, Compagno M, Houldsworth J, et al. Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. J Exp Med 2006;203:311-7.
24. Hamamoto R, Furukawa Y, Morita M, et al. SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nat Cell Biol 2004.
25. Peters AH, O'Carroll D, Scherthan H, et al. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 2001;107:323-37.
26. Gottlieb PD, Pierce SA, Sims RJ, et al. Bop encodes a muscle- restricted protein containing MYND and SET domains and is essential for cardiac differentiation and morphogenesis. Nat Genet 2002;31:25-32.
27. Tan X, Rotllant J, Li H, et al. SmyD1, a histone methyltransferase, is required for myofibril organization and muscle contraction in zebrafish embryos. Proc Natl Acad Sci U S A 2006;103:2713-8.
28. Kojc N, Zidar N, Vodopivec B, Gale N. Expression of CD34, alpha- smooth muscle actin, and transforming growth factor beta1 in squamous intraepithelial lesions and squamous cell carcinoma of the larynx and hypopharynx. Hum Pathol 2005;36:16-21.
29. Perez-Ordonez B, Beauchemin M, Jordan RC. Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol 2006;59:445-53.
30. Pauws E, Sijmons GG, Yaka C, Ris-Stalpers C. A novel homeobox gene overexpressed in thyroid carcinoma. Thyroid 2004;14:500-5.
31. Dias P, Parham DM, Shapiro DN, et al. Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma. Am J Pathol 1990;137:1283-91.
32. Ringel MD, Anderson J, Souza SL, et al. Expression ofthe sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer. Mod Pathol 2001;14:289-96.